Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)

Martha Sosa-Macias, Graciela E. Moya, Adrián Llerena, Ronald Ramírez, Enrique Terán, Eva M. Penãs-Lledó, Eduardo Tarazona-Santos, Carlos Galaviz-Hernández, Carolina Céspedes-Garro, Hildaura Acosta

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

9 Citas (Scopus)

Resumen

MESTIFAR 2014 28-30 November 2014, Panama City, Panama The CEIBA consortium was created within the Ibero-American network of Pharmacogenetics (RIBEF) to study population pharmacogenetics. The current status of these initiatives and results of the MESTIFAR project were analyzed in Panama, 28-30 November 2014. The MESTIFAR project focused on studying CYPs genetic polymorphisms in populations of different ethnic origin. So far, more than 6000 healthy volunteers have been evaluated, making this one of the largest population pharmacogenomic studies worldwide. Three symposia were organized, 'Pharmacogenetics of indigenous and mestizos populations and its clinical implications', 'Methodological innovation in pharmacogenetics and its application in health', and 'General discussion and concluding remarks', about mechanisms and proposals for training, diffusion of pharmacogenetics for Spanish-and Portuguese-speaking health professionals, and 'bench to bedside' pilot projects.

Idioma originalInglés
Páginas (desde-hasta)673-676
Número de páginas4
PublicaciónPharmacogenomics
Volumen16
N.º7
DOI
EstadoPublicada - 1 may. 2015

Huella

Profundice en los temas de investigación de 'Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)'. En conjunto forman una huella única.

Citar esto